Setback for Vectura/Hikma’s Advair Diskus generic
admin 11th May 2017 Uncategorised 0Chippenham, UK-based Vectura and its partner Hikma Pharmaceuticals have announced a major setback in the US after VR315, a generic version of GlaxoSmithKline’s asthma/COPD inhaler Advair Diskus, was rejected by the FDA.
More: Setback for Vectura/Hikma’s Advair Diskus generic
Source: News